@FiercePharma: North Carolina shuts down animal drug compounder. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Here's Baxter release on recall of 8 saline lots, 4 dextrose, 3 Lactated Ringer's Injection. Release | Follow @EricPFierce
> Novo Nordisk ($NVO) opened its new diabetes drug manufacturing plant in Russia, focusing on modern insulins in two types of injectors. Release
> Teva Pharmaceutical ($TEVA) is rolling out new data on its longer-acting formula of Copaxone at the American Academy of Neurology meeting this week. Release
> Novartis ($NVS) plans to unveil new data and analyses on its multiple sclerosis meds, including its blockbuster Gilenya pill, at the American Academy of Neurology meeting this week. Release
> Roche's ($RHHBY) anti-inflammatory drug Actemra is now under testing as a treatment for Type 1 diabetes. Report
> Mylan's ($MYL) proposed $29 billion buyout of Perrigo ($PRGO) could push its credit rating into junk territory if it's not careful about financing the deal with debt, analysts said. Report
> Novo Nordisk parent company Novo A/S tapped Bjarne Graven Larsen as its new CFO to replace the retiring Thorkil Christensen. Report
> Sales of medically important human antibiotics to the U.S. meat industry grew by 20% between 2009 and 2013, according to an FDA analysis. Report
Medical Device News
@FierceMedDev: FDA announces LuSys Labs' recall of its unapproved Ebola diagnostic. FierceDiagnostics article | Follow @FierceMedDev
@EmilyWFierce: NIH awards $11M to develop tests for drug-resistant bacteria. More from FierceDiagnostics | Follow @EmilyWFierce
> Qualcomm extends its Life2Net reach in deal with Cerner. Story
> ReCor Medical reels in $15M to recharge renal denervation efforts. Article
Biotech News
@FierceBiotech: Big Pharma partner: Check. Crossover round: Check. Hot tech: Check. IPO? Report | Follow @FierceBiotech
@JohnCFierce: Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact. News | Follow @JohnCFierce
> After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor. Article
> FDA clears the way for Arrowhead's hep B treatment, with a caveat. Story
> Drew Fromkin takes the helm at Langer's Blend Therapeutics. Item
Animal Health News
> Zoetis innovation lab seeks to create electronic health record for every U.K. farm animal. Report
> Jennie-O-Turkey plant struck by bird flu. Story
> Mylan seeks entry into animal health via $29B bid for Perrigo. Item
> North Carolina shuts down animal drug compounder. Article
> Chicago outbreak of dog flu has authorities pitching Merck vaccine. More
Biotech IT News
> Rise of Big Data prompts peer review rethink at Nature Biotechnology. Item
> Early user of Venter's DNA synthesizer reports saving time, money. Report
> BioXcel adds Takeda to its roster of A-list clients. More
> Eisai's new research unit taps Genomics for analysis support. Story
> Peking University inks Medidata deal as China inches into eClinical era. Article